Clinical Trial Detail

NCT ID NCT03459859
Title Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Justin Watts
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

Cytarabine + MLN4924

Age Groups: adult senior

No variant requirements are available.